共 50 条
- [21] Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123):: A potent, orally bioavailable CXCR2/CXCR1 receptor antagonistJOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (26) : 7603 - 7606Dwyer, Michael P.Yu, YounongChao, JianpingAki, CynthiaChao, JianhuaBiju, PurakkattleGirijavallabhan, ViyyoorRindgen, DianeBond, RichardMayer-Ezel, RosemaryJakway, JamesHipkin, R. WilliamFossetta, JamesGonsiorek, WaldemarBian, HongFan, XuedongTerminelli, CarolFine, JayLundell, DanielMerritt, J. RobertRokosz, Laura L.Kaiser, BerndLi, GeWang, WeiStauffer, TaraOzgur, LynneBaldwin, JohnTaveras, Arthur G.
- [22] Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesBIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (19) : 5705 - 5719Yoshida, TomohiroAkahoshi, FumihikoSakashita, HiroshiKitajima, HiroshiNakamura, MitsuharuSonda, ShujiTakeuchi, MasahiroTanaka, YoshihitoUeda, NaokoSekiguchi, SumieIshige, TakayukiShima, KyokoNabeno, MikaAbe, YujiAnabuki, JunSoejima, AkiYoshida, KumikoTakashina, YokoIshii, ShinichiKiuchi, SatokoFukuda, SayakaTsutsumiuchi, ReikoKosaka, KeigoMurozono, TakahiroNakamaru, YoshinobuUtsumi, HiroyukiMasutomi, NaoyaKishida, HiroyukiMiyaguchi, IkukoHayashi, Yoshiharu
- [23] 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemiaBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (03) : 983 - 988Anandan, Sampath-KumarWebb, Heather KayChen, DawnWang, Yi-XinAavula, Basker R.Cases, SylvaineCheng, YingDo, Zung N.Mehra, UpasanaVinh TranVincelette, JonWaszczuk, JoannaWhite, KathyWong, Kenneth R.Zhang, Le-NingJones, Paul D.Hammock, Bruce D.Patel, Dinesh V.Whitcomb, RandallMacIntyre, D. EuanSabry, JamesGless, Richard
- [24] (2S, 3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl4-oxo-2-(4-[1,2,4]triazolo[1,5-a]pyridin-6-ylphenyl)butanamide:: A selective α-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesJOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) : 3614 - 3627Edmondson, Scott D.Mastracchio, AnthonyMathvink, Robert J.He, JiafangHarper, BartPark, You-JungBeconi, MariaDi Salvo, JerryEiermann, George J.He, HuaibingLeiting, BarbaraLeone, Joseph F.Levorse, Dorothy A.Lyons, KathrynPatel, Reshma A.Patel, Sangita B.Petrov, AleksandrScapin, GiovannaShang, JackieRoy, Ranabir SinhaSmith, AaronWu, Joseph K.Xu, ShiyaoZhu, BingThornberry, Nancy A.Weber, Ann E.
- [25] 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: Lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activityBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) : 2741 - 2745Hale, JJBudhu, RJHolson, EBFinke, PEOates, BMills, SGMacCoss, MGould, SLDeMartino, JASpringer, MSSiciliano, SMalkowitz, LSchleif, WAHazuda, DMiller, MKessler, JDanzeisen, RHolmes, KLineberger, JCarella, ACarver, GEmini, E
- [26] Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt KinasesJOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (05) : 2059 - 2073Addie, MattBallard, PeterButtar, DavidCrafter, ClaireCurrie, GordonDavies, Barry R.Debreczeni, JuditDry, HannahDudley, PhilippaGreenwood, RyanJohnson, Paul D.Kettle, Jason G.Lane, ClareLamont, GillianLeach, AndrewLuke, Richard W. A.Morris, JeffOgilvie, DonaldPage, KenPass, MartinPearson, StuartRuston, Linette
- [27] 7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one is a novel competitive and selective inhibitor of dipeptidyl peptidase IV with an antihyperglycemic activityJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (03): : 1253 - 1257Yamazaki, KazutoYasuda, NobuyukiInoue, TakashiNagakura, TadashiKira, KazunobuShinoda, MasanobuSaeki, TakaoTanaka, Isao
- [28] Design and synthesis of a series of (2R)-N4-hydroxy-2-(3-hydroxybenzyl)-N1-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitorsJOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (21) : 3347 - 3350Yao, WQWasserman, ZRChao, MReddy, GShi, ELiu, RQCovington, MBArner, ECPratta, MATortorella, MMagolda, RLNewton, RQian, MXRibadeneira, MDChrist, DWexler, RRDecicco, CP
- [29] Design, Synthesis, Structure-Activity Relationships, and Docking Studies of 1-(γ-1,2,3-Triazol Substituted Prolyl)-(S)-3,3-Difluoropyrrolidines as a Novel Series of Potent and Selective Dipeptidyl Peptidase-4 InhibitorsCHEMICAL BIOLOGY & DRUG DESIGN, 2013, 81 (02) : 198 - 207Zhang, LeiSu, MingboLi, JingyaJi, XunWang, JiangLi, ZengLi, JiaLiu, Hong
- [30] (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1β and IL-18JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (02): : 509 - 516Wannamaker, WoodsDavies, RobertNamchuk, MarkPollard, JohnFord, PamellaKu, GeorgeDecker, CarolineCharifson, PaulWeber, PeterGermann, Ursula A.Kuida, KeisukeRandle, John C. R.